Does the use of supraglottic device in rabbits cause less injury than other airway management devices?
a Knowledge Summary by
Jasmine Gheini 1*
Sanaa Zaki PhD BVSc(hons) MANZCVs GradCertEdStud (Higher Education) 1
1Sydney School of Veterinary Science, Faculty of Science, University of Sydney, Camperdown NSW 2050
*Corresponding Author (jghe8559@uni.sydney.edu.au)
Vol 7, Issue 4 (2022)
Submitted: 09 Apr 2022
Published: 02 Dec 2022
Next review: 27 May 2024
DOI: 10.18849/VE.V7I4.608
There is an erratum to this paper published in Veterinary Evidence Vol 8, Issue 2 (2023): https://doi.org/10.18849/ve.v8i2.663
In rabbits, undergoing general anaesthesia, does the placement of a v-gel® device result in less airway trauma compared to the use of other airway management devices?
Clinical bottom line
Category of research question
Treatment
The number and type of study designs reviewed
Three papers were critically appraised, two blinded randomised experimental trial studies and one randomised crossover experimental trial study
Strength of evidence
Weak
Outcomes reported
One blinded randomised trial study demonstrated that the trauma to the upper airways of rabbits during anaesthesia is not significantly different between the use of v-gel® and an endotracheal tube. The other blinded randomised trial study demonstrated that the trauma to the upper airway caused by endotracheal intubation is significantly more than that caused by v-gel® placement. The randomised crossover trial study demonstrated that v-gel® placement causes more significant compression to the larynx compared to a laryngeal mask or face mask
Conclusion
The current evidence suggests that use of the v-gel® in rabbits causes less trauma / injury to the airways compared to placement of an endotracheal tube but not compared to the use of a laryngeal or face mask. However, based on the low number and quality of published studies, this evidence is weak, and better-quality studies are required to support the routine use of v-gel® over other airway devices in rabbits. While v-gel® may be a safer alternative for securing airways in rabbits compared to endotracheal intubation, knowing the injuries this device can cause to the upper airways is useful for managing rabbits during post anaesthesia recovery.
This Knowledge Summary has reviewed the available evidence on the use of a SGAD (v-gel®) in rabbit anaesthesia. Since writing a new design of a single use supraglottic airway device (SGAD) has been introduced; currently there is no published evidence on whether this new device has an impact on the risk of injury
How to apply this evidence in practice
The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.
Clinical scenario
As a veterinarian and owner of a small animal clinic with a high rabbit caseload, you would like to improve the protocols used for rabbit anaesthesia in your practice. You have recently heard of a new supraglottic airway device specific for rabbits named v-gel®, and you are considering introducing v-gel® in your clinic. You are wondering if this device is safer and causes less trauma in rabbits undergoing general anaesthesia compared to your current practice of using face masks for short procedures and endotracheal tubes for longer procedures.
The evidence
This critical appraisal identified three relevant studies. Two blinded randomised experimental trials (Comolli et al., 2020; and Engbers et al., 2017) and one randomised crossover experimental trial (Wenger et al., 2017).
Comolli et al. (2020) used a blinded randomised experimental trial approach to study on healthy female New Zealand White rabbits and determine if the placement of v-gel® would lead to faster, easier secure airways with less histological trauma compared to endoscopic endotracheal intubation with cuffed endotracheal tubes. The second blinded randomised experimental trial, Engbers et al. (2017) studied on healthy adult New Zealand White rabbits to determine similar goals to Comolli et al. (2020) however, the endotracheal intubation was preformed with a blind technique. Wegner et al. (2017) preformed a randomised crossover experimental trial study on healthy female New Zealand White rabbits to compare v-gel®, endotracheal tube, face mask and laryngeal mask in regard to ease of application, time of application and quality of seal.
Although randomised trials are considered to represent a moderate level of evidence, due to the small number of studies relevant to this PICO, and the study’s limitations such as small sample size, the findings from these three trials provided only a weak level of evidence that v-gel® devices cause less airway trauma when compared to other airway devices used in anaesthetised rabbits.
This Knowledge Summary has reviewed the available evidence on the use of a SGAD (v-gel®) in rabbit anaesthesia. Since writing a new design of a single use supraglottic airway device (SGAD) has been introduced; currently there is no published evidence on whether this new device has an impact on the risk of injury.
Summary of the evidence
Population: | Healthy (based on physical examination and health surveillance report) American Society of Anesthesiologists (ASA) score 1, 12 month old female New Zealand White rabbits (Oryctolagus cuniculus). The mean body weight ± SD was 2.57 ± 0.15 kg. |
Sample size: | 14 rabbits. |
Intervention details: | General:
Airway device placement:
Post-mortem: Four days after the anaesthetic event the animals were humanely euthanised by intravenous phenobarbital, tissue samples were collected (proximal larynx, distal larynx, 2 cm distal to larynx, and trachea at the tracheobronchial bifurcation) and fixed in formalin. Four days after fixation the tissue cross-sections were obtained, processed for histopathologic evaluation. The histological evaluation was performed by a blinded board-certified pathologist. |
Study design: | Blinded randomised experimental trial study. |
Outcome Studied: |
|
Main Findings (relevant to PICO question): |
|
Limitations: |
|
Population: | Healthy (American Society of Anesthesiologist [ASA] score >2) adult New Zealand White rabbits (n = 12 males, n = 3 females). |
Sample size: | 15 rabbits. |
Intervention details: | General:
Airway device placement:
Post-mortem:
|
Study design: | Blinded randomised experimental trial study. |
Outcome Studied: |
|
Main Findings (relevant to PICO question): |
Based on histological valuation, significantly greater tracheal mucosal and submucosal trauma was caused by endotracheal intubation compared to v-gel®. |
Limitations: |
|
Population: | Healthy (on basis of physical examination) female New Zealand White rabbits aged 7 months with a bodyweight of 5.10 ± 0.05 kg (mean ± SD). |
Sample size: | 10 rabbits. |
Intervention details: |
During recovery meloxicam (1 mg/kg subcutaneously) and Ringer’s lactate fluid (10 ml/kg intravenous [IV] over 30 minutes) were administered. Airway device placement:
Controlled manual ventilation (CMV): Rocuronium (0.3 mg/kg IV) was administered to induce apnoea and CMV (respiratory rate of 30 breaths/min) was performed for 4 minutes, followed by administration of sugammadex (4 mg/kg) before stopping CMV and allowing spontaneous ventilation. |
Study design: | Randomised crossover experimental trial. |
Outcome Studied: |
|
Main Findings (relevant to PICO question): |
|
Limitations: |
|
Appraisal, application and reflection
The increasing popularity of pet rabbits and the willingness of owners to pay for veterinary services (Mayer et al., 2017) means that more rabbits are presenting to veterinary practices for care. Veterinary practices need to accommodate the medical and welfare needs of rabbit patients and provide the necessary services, including general anaesthesia for surgical procedures such as ovariohysterectomy. General anaesthesia in rabbits has higher risks and higher mortality rates compared to cats and dogs (Brodbelt et al., 2008). The main factors contributing to this high risk are difficulty establishing a secure airway, underlying respiratory diseases, and cardiorespiratory complications during anaesthesia (Brodbelt et al., 2008; and Eatwell, 2014).
Securing the airway in rabbits is made difficult due to their unique airway anatomy. Rabbits have small and narrow mouths with large incisors, large molars and large tongues relative to their skull size, which makes it difficult to visualise the larynx for intubation (Donnelly & Vella, 2020). The most common methods used to secure the airway in rabbits are endotracheal intubation and placement of a well-fitting face mask. However, both endotracheal tubes and face masks have disadvantages that can impact the risk of anaesthesia (Eatwell, 2014). Face masks allow delivery of oxygen and anaesthetic gases but do not guarantee airway patency, thus can cause clinically significant hypoxaemia and hypercapnia. Endotracheal intubation can cause mucosal damage to the upper airways, leading to swelling and potential narrowing (Bateman et al., 2005; and Hawkins & Pascoe, 2021). Endotracheal intubation also requires significant training and practice. To address these issues, supraglottic airway devices (SGAD), similar to those used in human medicine, have been introduced and trialled as an alternative airway management device for rabbits. The use of a human supraglottic airway device was tested in rabbits and reported to cause lingual cyanosis, possibly due to pressure on the lingual vasculature (Crotaz, 2013; and Kazakos et al., 2007). In recent years, a new rabbit-specific SGAD (v-gel®) has been designed to decrease the risk of complications observed with the use of a human SGAD.
The three studies included in this critical appraisal reported varied outcomes. Significant limitations were identified for all three studies, including small sample size, use of multiple investigators for device placement and the use of rabbit breeds that differ in size from breeds commonly kept as pets.
Comolli et al. (2020) and Engbers et al. (2017) both compare the placement of v-gel® and an endotracheal tube (ETT) in rabbits. However, the findings of the two studies are incongruent. Comolli et al. (2020) concluded that overall, the trauma caused by v-gel® and ETT placement is not significantly different. The authors report that v-gel® caused more injury to the larynx and epiglottis, and ETT caused more injury to the trachea, although the differences between the devices were not statistically significant. In contrast, Engbers et al. (2017) identified that ETT causes more significant injury to tracheal mucosal and submucosal airways compared to v-gel®. The different findings in these two studies could be due to differences in ETT placement method, given that Comolli et al. (2020) used endoscopic guided endotracheal intubation, while Engbers et al. (2017) performed a blind technique for placement of ETT. Another possible explanation could be the experience of investigators placing the devices. Goldmann & Ferson (2005) report that training for airway management by anaesthetists can reduce anaesthesia-related morbidity and mortality. The third study (Wenger et al., 2017) compared two additional airway devices, laryngeal mask, and face mask, in addition to v-gel® and ETT. Wenger et al. (2017) mainly studied the amount of laryngeal compression caused by the different devices and found that v-gel® compressed the larynx more significantly than laryngeal mask and face mask. This study did not look at the direct injury to the upper airways, but it was assumed that compression of the larynx would lead to airway damage, and therefore was relevant to the PICO question.
The methods used to evaluate airway injury were similar between the Comolli et al. (2020) and Engbers et al. (2017) studies. Both papers performed histological evaluation of post-mortem samples following anaesthesia. However, the time of sample collection differed between the studies. In Comolli et al. (2020) study samples were collected 4 days after anaesthesia. In Engbers et al. (2017) study samples were collected 2 hours after anaesthesia. The different time intervals between device placement and sample collection could impact the observed histological changes to the tissues. Collection after 2 hours would show any acute injury changes, such as acute inflammation and damage to tissue integrity, but not long-term damage such as chronic inflammatory infiltrate, fibrosis or stricture formation which could take days or weeks to develop. On the other hand, collection of tissue after 4 days may fail to identify the extent of the acute inflammatory changes immediately following the injury. If the tissue damage is significant but not severe enough to cause chronic change, it may still cause airway complications during the recovery period with resolution prior to sample collection at day 4 (Anderson, 2013).
The level of experience of the investigators performing the placement of each airway device differed between the three studies. In the two blinded studies (Comolli et al., 2020; and Engbers et al., 2017) the pathologist evaluating the tissue histology was blinded to treatment, however, the investigators placing the airway devices could not be blinded due to the nature of the procedure. This could impact the technique used by the investigator due to unconscious bias about which device was superior. Moreover, in the Engbers et al. (2017) study the investigator was more experienced using ETT compared to the v-gel®. In Wenger et al. (2017) the level of experience with device placement was not clear as multiple investigators were involved. One limitation that stood out in the Comolli et al. (2020) study is the use of visual inspection of upper airway. The authors do not describe how the measurements were recorded and analysed for visual inspections of the upper airways. Finally, it should be considered that the studies included only one breed of rabbit, that does not reflect the common pet rabbit breeds.
Considering the findings and limitations of each study, there is currently insufficient evidence to confirm that the use of v-gel® during general anaesthesia in rabbits causes less injury to the upper airways compared to other airway management devices. More research such as randomised blinded clinical trial with larger sample size can be helpful to learn if v-gel® use in rabbits is beneficial to them routinely in the clinical setting, given that less damage to the upper airways, will lead to better recovery from anaesthesia and fewer complications.
Methodology Section
Search Strategy | |
Databases searched and dates covered: | CAB Abstracts via Web of Science (1910–present)
Scopus (1960–present) Web of Science Core Collections (1900–present) Medline (PubMed) (1900–present) |
Search strategy: | CAB Abstracts and Web of Science Core Collections:
Scopus:
PubMed: (((Rabbit OR Rabbits OR Oryctolagus cuniculus) AND (Anaesthesia OR general anaesthesia)) AND (V-gel OR Supraglottic airway device OR SGA)) AND (Endotracheal tube OR tracheal tube OR endotracheal intubation OR airway OR mask OR complications OR laryngeal tube) |
Dates searches performed: | 27 May 2022 |
Exclusion / Inclusion Criteria | |
Exclusion: | Papers written in English.
Case series, case control studies, clinical trials and systemic reviews. Study population: rabbits undergoing general anaesthesia. Intervention: use of v-gel®. Comparator: other airway control devices. Outcomes: include measures of airway trauma or damage or inflammation. |
Inclusion: | Case studies, narrative reviews, opinion pieces, methods papers, non-English publications. |
Search Outcome | ||||||||
Database |
Number of results |
Excluded – It did not include rabbits |
Excluded – Non-English papers |
Excluded – Did not focus on v-gels® |
Excluded – Did not focus on trauma / injury / damage to the airways |
Excluded – Case studies, narrative reviews, opinion pieces, methods papers |
Excluded – Duplicates |
Total relevant papers |
CAB Abstracts |
18 | 1 | 1 | 5 | 4 | 4 | 0 | 3 |
Web of Science |
10 | 2 | 0 | 1 | 2 | 0 | 5 | 0 |
PubMed |
16 | 1 | 0 | 4 | 2 | 1 | 8 | 0 |
Scopus |
18 | 0 | 0 | 0 | 0 | 0 | 18 | 0 |
Total relevant papers when duplicates removed |
3 |
I would like to dedicate this paper in memory of my professor Dr Frazer Allan. I would also like to thank Sanaa Zaki for holding my hand throughout this project.
Jasmine Gheini: https://orcid.org/0000-0002-7243-6239
Sanaa Zaki: https://orcid.org/0000-0002-6393-6055
The authors declare no conflicts of interest.
Intellectual Property Rights
Authors of Knowledge Summaries submitted to RCVS Knowledge for publication will retain copyright in their work, and will be required to grant to RCVS Knowledge a non-exclusive licence to publish including but not limited to the right to publish, re-publish, transmit, sell, distribute and otherwise use the materials in all languages and all media throughout the world, and to licence or permit others to do so.
Disclaimer
Knowledge Summaries are a peer-reviewed article type which aims to answer a clinical question based on the best available current evidence. It does not override the responsibility of the practitioner. Informed decisions should be made by considering such factors as individual clinical expertise and judgement along with patient’s circumstances and owners’ values. Knowledge Summaries are a resource to help inform and any opinions expressed within the Knowledge Summaries are the author's own and do not necessarily reflect the view of the RCVS Knowledge. Authors are responsible for the accuracy of the content. While the Editor and Publisher believe that all content herein are in accord with current recommendations and practice at the time of publication, they accept no legal responsibility for any errors or omissions, and make no warranty, express or implied, with respect to material contained within. For further information please refer to our Terms of Use.